Daily Sabah logo

Politics
Diplomacy Legislation War On Terror EU Affairs Elections News Analysis
TÜRKİYE
Istanbul Education Investigations Minorities Expat Corner Diaspora
World
Mid-East Europe Americas Asia Pacific Africa Syrian Crisis Islamophobia
Business
Automotive Economy Energy Finance Tourism Tech Defense Transportation News Analysis
Lifestyle
Health Environment Travel Food Fashion Science Religion History Feature Expat Corner
Arts
Cinema Music Events Portrait Reviews Performing Arts
Sports
Football Basketball Motorsports Tennis
Opinion
Columns Op-Ed Reader's Corner Editorial
PHOTO GALLERY
JOBS ABOUT US RSS PRIVACY CONTACT US
© Turkuvaz Haberleşme ve Yayıncılık 2023

Daily Sabah logo

عربي
  • Politics
    • Diplomacy
    • Legislation
    • War On Terror
    • EU Affairs
    • Elections
    • News Analysis
  • TÜRKİYE
    • Istanbul
    • Education
    • Investigations
    • Minorities
    • Expat Corner
    • Diaspora
  • World
    • Mid-East
    • Europe
    • Americas
    • Asia Pacific
    • Africa
    • Syrian Crisis
    • Islamophobia
  • Business
    • Automotive
    • Economy
    • Energy
    • Finance
    • Tourism
    • Tech
    • Defense
    • Transportation
    • News Analysis
  • Lifestyle
    • Health
    • Environment
    • Travel
    • Food
    • Fashion
    • Science
    • Religion
    • History
    • Feature
    • Expat Corner
  • Arts
    • Cinema
    • Music
    • Events
    • Portrait
    • Reviews
    • Performing Arts
  • Sports
    • Football
    • Basketball
    • Motorsports
    • Tennis
  • Gallery
  • Opinion
    • Columns
    • Op-Ed
    • Reader's Corner
    • Editorial
  • TV
  • Life
  • Health
  • Environment
  • Travel
  • Food
  • Fashion
  • Science
  • Religion
  • History
  • Feature
  • Expat Corner

Novavax applies for EU vaccine approval, decision 'within weeks'

by Agencies

Nov 17, 2021 - 6:10 pm GMT+3
A woman holds a small bottle labeled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in front of displayed Novavax logo in this illustration taken, Oct. 30, 2020. (Reuters Photo)
A woman holds a small bottle labeled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in front of displayed Novavax logo in this illustration taken, Oct. 30, 2020. (Reuters Photo)
by Agencies Nov 17, 2021 6:10 pm
RECOMMENDED
Snow geese take off from a field in Ruthsburg, Maryland, U.S., Jan. 25, 2023. (AFP Photo)

Concerning bird flu spreads through mammals but low risk to humans

health

Pharmaceutical giant Novavax applied to the European Union's drug regulator for their COVID-19 vaccine, with the EU saying Wednesday that a decision will be out "within weeks."

The regulator pointed out that this is provided the data it has received from the drugmaker was sufficient to prove the shot's effectiveness.

The protein-based vaccine has been under a rolling review since February, the European Medicines Agency (EMA) said. The vaccine's assessment, which goes under the brand name Nuvaxovid, would be carried out "under an accelerated timeline," the European Medicines Agency (EMA) said.

"If EMA concludes that the benefits of Nuvaxovid outweigh its risks in protecting against COVID-19, it will recommend granting a conditional marketing authorization," it said.

If approved by the EMA, the shot would be the region's fifth coronavirus vaccine, joining those from Pfizer-BioNTech, Moderna, AstraZeneca and Johnson & Johnson.

The major approval could come much ahead of authorization in the United States, where Novavax had to resolve manufacturing issues and expects to file for approval by the end of the year.

The EMA said two of its advisory panels were looking into various plans submitted by Novavax on risk management, and development and studies of the vaccine for use in children.

Novavax's shot received its first emergency use approval earlier this month in Indonesia. The company has also sought backing from the World Health Organization (WHO). The Philippines on Wednesday authorized emergency use of a version made by India's Serum Institute.

RECOMMENDED
Snow geese take off from a field in Ruthsburg, Maryland, U.S., Jan. 25, 2023. (AFP Photo)

Concerning bird flu spreads through mammals but low risk to humans

health
  • shortlink copied
  • RELATED TOPICS
    fight-against-terrorism DEUTSCHE-BANK US-LIBYA-RELATIONS
    KEYWORDS
    covid-19 vaccine novavax european union approval nuvaxovid
    The Daily Sabah Newsletter
    Keep up to date with what’s happening in Turkey, it’s region and the world.
    You can unsubscribe at any time. By signing up you are agreeing to our Terms of Use and Privacy Policy. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
    A Turkish Airlines aircraft is seen as a snow plow cleans runway at Istanbul Airport, Istanbul, Türkiye, Jan. 24, 2022. (DHA Photo)

    Over 200 flights cancelled in Istanbul due to expected snowstorm

    snowstorm
    A view of the rubble of a building hit by the earthquake in Pazarcık, Kahramanmaraş, Feb. 6, 2023. (AA Photo)

    Death toll rises to 1,541 after magnitude 7.7 quake rocks SE Türkiye

    EARTHQUAKE

    Gaziantep Castle collapses after magnitude 7.7 quake hit Türkiye

    EARTHQUAKE

    Kahramanmaraş, Hatay, Gaziantep suspend flights after 7.7 earthquake

    EARTHQUAKE
    Lake Sapanca
    10 stunning Turkish lakes to visit year-round
    PHOTOGALLERY
    • POLITICS
    • Diplomacy
    • Legislation
    • War On Terror
    • EU Affairs
    • News Analysis
    • TÜRKİYE
    • Istanbul
    • Education
    • Investigations
    • Minorities
    • Diaspora
    • World
    • Mid-East
    • Europe
    • Americas
    • Asia Pacific
    • Africa
    • Syrian Crisis
    • İslamophobia
    • Business
    • Automotive
    • Economy
    • Energy
    • Finance
    • Tourism
    • Tech
    • Defense
    • Transportation
    • News Analysis
    • Lifestyle
    • Health
    • Environment
    • Travel
    • Food
    • Fashion
    • Science
    • Religion
    • History
    • Feature
    • Expat Corner
    • Arts
    • Cinema
    • Music
    • Events
    • Portrait
    • Performing Arts
    • Reviews
    • Sports
    • Football
    • Basketball
    • Motorsports
    • Tennis
    • Opinion
    • Columns
    • Op-Ed
    • Reader's Corner
    • Editorial
    • Photo gallery
    • Jobs
    • privacy
    • about us
    • contact us
    • RSS
    © Turkuvaz Haberleşme ve Yayıncılık 2021